Paradigm shift in vertebral eosinophilic granuloma

dc.authorid0000-0002-1847-2562
dc.authorid0000-0002-8617-9958
dc.authorid0000-0003-1295-5528
dc.contributor.authorÖzbek, Muhammet Arif
dc.contributor.authorİpek, Veyselkarani
dc.contributor.authorDinç, Cem
dc.date.accessioned2024-11-04T06:13:51Z
dc.date.available2024-11-04T06:13:51Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Beyin ve Sinir Cerrahisi Ana Bilim Dalı
dc.description.abstractObjective: Eosinophilic granuloma is the most common type of Langerhans cell histiocytosis. Vertebral bone involvement of eosinophilic granuloma is a rare disease. There are few studies in the literature on patients with vertebral bone involvement diagnosed with eosinophilic granuloma. There is still no clear protocol for the treatment of patients with vertebral involvement with eosinophilic granuloma. This article is a summary of the clinical follow-ups of our 6 cases diagnosed with spinal eosinophilic granuloma. We changed the chemotherapy protocol or extended the duration of chemotherapy in patients with progressive disease. Methods: In this study, there are six patients (4 male and 2 female) with vertebral involvement of eosinophilic granuloma in our hospital between September 2017 and August 2022. The clinical findings, radiological images, treatments and follow-up results of the patients were analyzed retrospectively. Results: In the follow-ups, a new vertebral bone involvement was observed in two patients and a femoral bone involvement was observed in another patient. One patient with neurological deficit underwent surgical treatment. Chemotherapy treatment was given to four patients with multiple bone involvement or recurrence. No recurrence was observed in three patients who started chemotherapy treatment after recurrence. Conclusions: Surgical treatment should be considered in patients with neurological deficits and spinal instability. According to the results of our study, patients with multiple bone or systemic involvement and no neurological deficit should receive chemotherapy treatment. We recommend changing the chemotherapy protocol or extending the chemotherapy duration in patients with progressive disease.
dc.identifier.citationÖzbek, M. A., İpek, V. ve Dinç, C. (2023). Paradigm shift in vertebral eosinophilic granuloma. Ukrainian Neurosurgical Journal, 29(1), 30-37. http://dx.doi.org/10.25305/unj.268336
dc.identifier.doi10.25305/unj.268336
dc.identifier.endpage37
dc.identifier.issn2663-9084
dc.identifier.issue1
dc.identifier.scopus2-s2.0-85201000900
dc.identifier.scopusqualityN/A
dc.identifier.startpage30
dc.identifier.urihttp://dx.doi.org/10.25305/unj.268336
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12844
dc.identifier.volume29
dc.indekslendigikaynakScopus
dc.institutionauthorÖzbek, Muhammet Arif
dc.institutionauthorİpek, Veyselkarani
dc.institutionauthorDinç, Cem
dc.language.isoen
dc.relation.ispartofUkrainian Neurosurgical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsAttribution 4.0 International*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectEosinophilic Granuloma
dc.subjectSpine
dc.subjectTreatment
dc.titleParadigm shift in vertebral eosinophilic granuloma
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Özbek-Muhammet Arif-2024.pdf
Boyut:
1.13 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: